提高院前输血占总输血量比例与改善住院结局相关:失血性休克试验的二次分析
该研究为回顾性队列研究,基于六项失血性休克试验的统一数据库,纳入2340例受试者,其中1024例(43.8%)接受院前输血。排除4小时内死亡及24小时内未输血者。主要终点为24小时死亡率,次要终点包括28天死亡率、ICU自由天数、呼吸机自由天数及急性肺损伤(ALI)发生率。多因素分析显示,院前输血占总输血量比例每增加10%,ALI风险降低8.8%(95%CI:1.8-15.4%;P=0.015),与死亡率、ICU自由天数及呼吸机自由天数无显著关联。在院前输血者中,该比例每增加10%,ALI风险降低16.7%(95%CI:5.3-26.6%;P=0.005;n=375),ICU自由天数增加0.21天(95%CI:0.01-0.41;P=0.036;n=909)。结论认为增加院前阶段复苏比例与改善次要临床结局相关,支持尽早启动输血。
要点
- 院前输血占总输血量比例每增加10%,急性肺损伤风险降低8.8%(95%CI:1.8-15.4%;P=0.015)。
- 在院前输血者中,该比例每增加10%,ALI风险降低16.7%(95%CI:5.3-26.6%;P=0.005;n=375),ICU自由天数增加0.21天(95%CI:0.01-0.41;P=0.036;n=909)。
- 该比例与24小时死亡率、28天死亡率、呼吸机自由天数无显著关联。
- 院前输血者较仅院内输血者年龄更大(中位41 vs 38岁,P=0.013)、钝性损伤更多(81.6% vs 66.0%;P<0.001)、空中转运更多(77.4% vs 47.1%;P<0.001)、ISS更高(中位29 vs 25,P<0.001)。
- 作者认为这些数据支持对出血尽早启动输血。
适用人群与场景
- 创伤性失血性休克患者,来自六项失血性休克试验的统一数据库。
- 排除4小时内死亡者及24小时内未输血者。
研究设计与关键结果
- 研究类型为回顾性队列研究,基于六项失血性休克试验的统一数据库,共纳入2340例受试者,其中1024例(43.8%)接受院前输血。
- 院前输血者与仅院内输血者比较:年龄中位41 vs 38岁(P=0.013),钝性损伤81.6% vs 66.0%(P<0.001),院间转运13.3% vs 4.3%(P<0.001),空中转运77.4% vs 47.1%(P<0.001),ISS中位29 vs 25(P<0.001)。
- 院前输血占总输血量比例每增加10%,ALI风险降低8.8%(95%CI:1.8-15.4%;P=0.015),与死亡率、ICU自由天数及呼吸机自由天数无显著关联。
- 在院前输血者中,该比例每增加10%,ALI风险降低16.7%(95%CI:5.3-26.6%;P=0.005;n=375),ICU自由天数增加0.21天(95%CI:0.01-0.41;P=0.036;n=909)。
- 敏感性分析(仅院前输血者、排除创伤性脑损伤)已进行。
证据类型、等级与局限
- 证据类型:回顾性队列研究(二次分析),证据等级为治疗/管理Level III。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为这些数据支持对出血尽早启动输血。
- 该研究显示院前输血占总输血量比例增加与ALI风险降低及院前输血者ICU自由天数增加相关,与死亡率无显著关联。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Early transfusion improves survival of traumatic hemorrhage. We hypothesized that increased ratios of prehospital to total blood (red blood cell or whole blood) transfusion within 24 hours would be associated with improved outcomes.
METHODS: A retrospective cohort study using a harmonized database of six hemorrhagic shock trials was conducted. Decedents within 4 hours and those not transfused within 24 hours were excluded. The primary outcome was 24-hour mortality; secondary outcomes included 28-day mortality, intensive care unit (ICU)-free and ventilator-free days, and incidence of acute lung injury (ALI). Prehospital blood ratio was calculated as volume prehospital transfusion:volume 24-hour total transfusion (prehospital plus 24-h total at the admitting facility). Multivariable analyses adjusted for age, sex, mechanism, Injury Severity Score (ISS), inter-facility transfer, transport mode, arrival systolic blood pressure and Glasgow Coma Scale, treatment group, trial, and transfusion volume were conducted. Sensitivity analyses (prehospital-only recipients, excluding traumatic brain injury) were conducted.
RESULTS: Overall, 2,340 subjects were eligible, and 1,024 (43.8%) received prehospital blood. Prehospital recipients were older (median age 41 vs. 38 y, P =0.013), more likely blunt mechanism (81.6% vs. 66.0%; P <0.001), more likely transferred (13.3% vs. 4.3%; P <0.001), more likely transported by air (77.4% vs. 47.1%; P <0.001), and had higher ISS (median 29 vs. 25, P <0.001) compared with in-hospital only recipients. For every 10% increase in prehospital (PH):total blood ratio, there was an 8.8% decrease in odds of ALI (95% CI: 1.8-15.4%; P =0.015) and no significant association with mortality, ICU-free or ventilator-free days. Among prehospital recipients, for every 10% increase in PH:total blood ratio, there was a 16.7% decrease in odds of ALI (95% CI: 5.3-26.6%; P =0.005; n=375) and 0.21 (95% CI: 0.01-0.41; P =0.036; n=909) more ICU-free days.
CONCLUSIONS: An increased proportion of resuscitation in the prehospital phase of care was associated with improved secondary clinical outcomes for select subjects. These data support initiating transfusion for hemorrhage as early as feasible. ( J Trauma Acute Care Surg . 2026;101: 39-47. Copyright © 2026 Wolters Kluwer Health, Inc. All rights reserved.).
LEVEL OF EVIDENCE: Therapeutic/Care Management; Level III.
参考来源
- Furman L, Feeney EV, Bizri N, et al. Increased prehospital to total blood product administration associated with improved hospital outcomes: A secondary analysis of hemorrhagic shock trials. J Trauma Acute Care Surg. 2026. PMID: 41941349. doi:10.1097/TA.0000000000004970
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。